Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × telotristat ethyl × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Serotonin Syndrome 1 Carcinoid Heart Disease 1

Interventions

Radiotherapy 257 Cisplatin 236 Cyclophosphamide 193 Paclitaxel 148 Doxorubicin 147 Carboplatin 136 Vincristine 131 Etoposide 117 Filgrastim 113 Fluorouracil 101 Gemcitabine 100 Docetaxel 97 Dexamethasone 89 Methotrexate 86 Cytarabine 86 Leucovorin 77 Prednisone 75 Gene Expression Profiling 72 Granulocyte Colony-Stimulating Factor 60 Capecitabine 53 Irinotecan 50 Specimen Handling 47 Radiation 46 Oxaliplatin 46 Magnetic Resonance Spectroscopy 46 Ifosfamide 46 Polymerase Chain Reaction 44 Radiotherapy, Conformal 42 Platinum 42 Immunohistochemistry 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065165 2020-02-05

TELEFIRST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡